Publications by authors named "Alessio Molinari"

Claim this Profile
N
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment.
Salvatore Di Maria, Francesca Picarazzi, Mattia Mori, Annarita Cianciusi, Anna Carbone, Alessio Molinari

Bioorg Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma.
Enrico Rango, Lucia D'Antona, Giulia Iovenitti, Annalaura Brai, Arianna Mancini, Alessio Molinari

Eur J Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AuNP Pyrazolo[3,4-]pyrimidine Nanosystem in Combination with Radiotherapy against Glioblastoma.
Alessio Molinari, Giulia Iovenitti, Arianna Mancini, Giovanni Luca Gravina, Monia Chebbi

ACS Med Chem Lett· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.
Anna Lucia Fallacara, Claudio Zamperini, Ana Podolski-Renić, Jelena Dinić, Tijana Stanković, Alessio Molinari

Cancers (Basel)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.
Alessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, Claudio Zamperini, Federica Poggialini

Bioorg Med Chem Lett· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia.
Francesca Musumeci, Chiara Greco, Giancarlo Grossi, Alessio Molinari, Silvia Schenone

Cancers (Basel)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors.
Cinzia Maria Francini, Francesca Musumeci, Anna Lucia Fallacara, Lorenzo Botta, Alessio Molinari

Molecules· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model.
Giulia Vignaroli, Giulia Iovenitti, Claudio Zamperini, Federica Coniglio, Pierpaolo Calandro, Alessio Molinari

J Med Chem· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis: HCK in erythropoietin/PI3K pathway.
Fernanda Marconi Roversi, Fernando Vieira Pericole, João Agostinho Machado-Neto, Adriana da Silva Santos Duarte, Ana Leda Longhini, Alessio Molinari

Biochim Biophys Acta Mol Basis Dis· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis